Beta
38765

Prenatal screening for preeclampsia using maternal plasma angiogenic markers

Thesis

Last updated: 06 Feb 2023

Subjects

-

Tags

Clinical & Chemical Pathology

Advisors

Abou-Yousuf, Hazem E. , Gaber, Khaled R. , Mahmoud, Einas H.

Authors

Muhammad, May Muhammad Khalil

Accessioned

2017-04-26 12:31:26

Available

2017-04-26 12:31:26

type

M.Sc. Thesis

Abstract

Preeclampsia is considered one of the main reasons for 34% preventable maternal mortality in Egypt. It is the secondleading cause of maternal mortality after bleeding andhemorrhage. VEGF decreased before the occurrence of preeclampsia byat least 5 weeks of gestation but this decrease did not differentiategestational hypertension from preeclampsia. On the same level as an angiogenic marker, the medianlevel of PIGF was statistically significant when comparing its levelin preeclampsia with controls (P<0.0005).Soluble Endoglin as an anti-angiogenic marker wasincreased in cases of gestational hypertension and preeclampsia.The median level of sEng had a statistically significant difference incomparing gestational hypertension and preeclampsia group withcontrols (P<0.0005).

Issued

1 Jan 2007

DOI

http://dx.doi.org/10.21473/iknito-space/32709

Details

Type

Thesis

Created At

28 Jan 2023